FDA recalls another blood pressure drug for possible cancer risk; Third one since August- Losartan Potassium Hydrochlorothiazide
https://www.usatoday.com/story/money/nation-now/2018/11/13/fda-losartan-recall-cancer-risk-tied-blood-pressure-drug/1985858002/